{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:11:54Z","timestamp":1776701514577,"version":"3.51.2"},"reference-count":32,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Telomerase activity, telomere length, stem\/progenitor cell production, and function of CD34+ cells from cord blood (CB), bone marrow, and mobilized peripheral blood were evaluated in long-term cultures. CB cells were cultured either on OP-9 stromal cells transduced with an adenovector expressing thrombopoietin (TPO) or stimulated by a cytokine cocktail in the absence of stroma, with, in one method, CD34+ cells reisolated at monthly intervals for passage. Continuous expansion of stem cells as measured by in vitro cobblestone area and secondary colony-forming assays was noted for 18 to 20 weeks and by severe combined immunodeficiency (SCID)-repopulating cells (SRCs), capable of repopulating and serially passage in nonobese diabetic\/SCID mice, for 16 weeks. Despite this extensive proliferation, telomere length initially increased and only at late stages of culture was evidence of telomere shortening noted. This telomere stabilization correlated with maintenance of high levels of telomerase activity in the CD34+ cell population for prolonged periods of culture. Cytokine-stimulated cultures of adult CD34+ cells showed CD34+ and SRC expansion (6-fold) for only 3 to 4 weeks with telomere shortening and low levels of telomerase. There is clearly a clinical value for a system that provides extensive stem cell expansion without concomitant telomere erosion. (Blood. 2004;103:4440-4448)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3079","type":"journal-article","created":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T01:14:24Z","timestamp":1074561264000},"page":"4440-4448","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":74,"title":["Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication"],"prefix":"10.1182","volume":"103","author":[{"given":"Loretta","family":"Gammaitoni","sequence":"first","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja C.","family":"Weisel","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gunetti","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Da","family":"Wu","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bruno","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Pinelli","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bonati","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm A. S.","family":"Moore","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Piacibello","sequence":"additional","affiliation":[{"name":"From the Laboratory of Clinical Oncology, IRCC\u2014Institute for Cancer Research and Treatment, Torino, Italy; James Ewing Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Department of Clinical Sciences, Section of Hemato-Oncology, University of Parma Medical School, Parma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021220020687200_REF1","unstructured":"Moore MAS. In vitro and in vivo hematopoiesis. In: Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM, eds. Atlas of Blood Cells: Function and Pathology. 3rd ed. Milan, Italy: Arti Grafiche Salea; 2003: 1-38."},{"key":"2020021220020687200_REF2","doi-asserted-by":"crossref","unstructured":"Kondo M, Wagers AJ, Manz MG, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21: 759-806.","DOI":"10.1146\/annurev.immunol.21.120601.141007"},{"key":"2020021220020687200_REF3","doi-asserted-by":"crossref","unstructured":"Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol. 2002;41: 29-40.","DOI":"10.1016\/S1040-8428(01)00188-3"},{"key":"2020021220020687200_REF4","doi-asserted-by":"crossref","unstructured":"Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 1997;90: 182-193.","DOI":"10.1182\/blood.V90.1.182"},{"key":"2020021220020687200_REF5","unstructured":"Engelhardt M, MacKenzie K, Drullinsky P, Silver RT, Moore MAS. Telomerase activity and telomere length in acute and chronic leukemia, preand post-ex vivo culture. Cancer Res. 2000;60: 610-617."},{"key":"2020021220020687200_REF6","doi-asserted-by":"crossref","unstructured":"Vazir H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994:91: 9857-9860.","DOI":"10.1073\/pnas.91.21.9857"},{"key":"2020021220020687200_REF7","doi-asserted-by":"crossref","unstructured":"Moore MAS. Commentary: Umbilical cord blood: an expendable resource. J Clin Invest. 2000;105: 855-856.","DOI":"10.1172\/JCI9094"},{"key":"2020021220020687200_REF8","unstructured":"Rubinstein P, Carrier C, Carpenter C, et al. Graft selection in unrelated placental\/umbilical cord blood (PCB) transplantation: influence and weight of HLA match and cell dose on engraftment and survival [abstract]. Blood. 2000;96: 588a."},{"key":"2020021220020687200_REF9","doi-asserted-by":"crossref","unstructured":"Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344: 1815-1822.","DOI":"10.1056\/NEJM200106143442402"},{"key":"2020021220020687200_REF10","doi-asserted-by":"crossref","unstructured":"Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 2003;101: 4233-4244.","DOI":"10.1182\/blood-2002-08-2510"},{"key":"2020021220020687200_REF11","doi-asserted-by":"crossref","unstructured":"Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (Ucb) transplantation with ex-vivo expanded UCB cells: results of a phase I trial using the Aastrom Replicell system. Blood. 2003;101: 5061-5067.","DOI":"10.1182\/blood-2001-12-0290"},{"key":"2020021220020687200_REF12","doi-asserted-by":"crossref","unstructured":"Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89: 2644-2653.","DOI":"10.1182\/blood.V89.8.2644"},{"key":"2020021220020687200_REF13","doi-asserted-by":"crossref","unstructured":"Piacibello W, Sanavio F, Garetto L, et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 1998;12: 718-727.","DOI":"10.1038\/sj.leu.2401003"},{"key":"2020021220020687200_REF14","doi-asserted-by":"crossref","unstructured":"Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93: 3736-3749.","DOI":"10.1182\/blood.V93.11.3736"},{"key":"2020021220020687200_REF15","doi-asserted-by":"crossref","unstructured":"Issad C, Croisille L, Katz A, Vainchenker W, Coulombel L. A murine stromal cell line allows the proliferation of very primitive human CD34++\/CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 1993;81: 2916-2924.","DOI":"10.1182\/blood.V81.11.2916.2916"},{"key":"2020021220020687200_REF16","unstructured":"Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 1994;8: 1095-1104."},{"key":"2020021220020687200_REF17","doi-asserted-by":"crossref","unstructured":"Moore KA, Ema H, Lemischka IR. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 1997;89: 4337-4347.","DOI":"10.1182\/blood.V89.12.4337"},{"key":"2020021220020687200_REF18","unstructured":"Feugier P, Shieh J-H, Jo D-Y, et al. Long-term expansion of hematopoietic cells in CD34+ cell co-cultures with murine osteopetrotic stromal cells, OP9, transfected with adenovirus expressing thrombopoietin [abstract]. Blood. 2000;96: 666a."},{"key":"2020021220020687200_REF19","doi-asserted-by":"crossref","unstructured":"Feugier P, Jo D-Y, Shieh J-H, et al. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, C-kit ligand and Flk-2 ligand. J Hematother Stem Cell Res. 2002;11: 127-138.","DOI":"10.1089\/152581602753448595"},{"key":"2020021220020687200_REF20","doi-asserted-by":"crossref","unstructured":"Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood. 1999;94: 2161-2168.","DOI":"10.1182\/blood.V94.7.2161.419k32_2161_2168"},{"key":"2020021220020687200_REF21","doi-asserted-by":"crossref","unstructured":"Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD\/SCID-repopulating cells by stem cell factor, Flk2\/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105: 1013-1021.","DOI":"10.1172\/JCI8583"},{"key":"2020021220020687200_REF22","doi-asserted-by":"crossref","unstructured":"Gammaitoni L, Bruno S, Sanavio F, et al. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol. 2003;31: 261-270.","DOI":"10.1016\/S0301-472X(02)01077-9"},{"key":"2020021220020687200_REF23","doi-asserted-by":"crossref","unstructured":"Jo D-Y, Rafii S, Hamada T, Moore MAS. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000;105: 101-111.","DOI":"10.1172\/JCI7954"},{"key":"2020021220020687200_REF24","doi-asserted-by":"crossref","unstructured":"Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16: 743-747.","DOI":"10.1038\/nbt0898-743"},{"key":"2020021220020687200_REF25","doi-asserted-by":"crossref","unstructured":"Wu K, Orme L, Shaughnessy J, Jacobson JJ, Barlogie B, Moore MAS. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status and overall survival. Blood. 2003;101: 4982-4989.","DOI":"10.1182\/blood-2002-11-3451"},{"key":"2020021220020687200_REF26","doi-asserted-by":"crossref","unstructured":"Kodama H, Nose M, Niida S, Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 1991;73: 1291-1294.","DOI":"10.1084\/jem.173.5.1291"},{"key":"2020021220020687200_REF27","doi-asserted-by":"crossref","unstructured":"MacKenzie KL, Franco S, May C, Sadelain M, Moore MAS. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp Cell Res. 2000;259: 336-350.","DOI":"10.1006\/excr.2000.4982"},{"key":"2020021220020687200_REF28","doi-asserted-by":"crossref","unstructured":"Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S, Moore MAS. Clonal variation in phenotype and lifespan of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT). Exp Cell Res. 2001,268: 14-25.","DOI":"10.1006\/excr.2001.5264"},{"key":"2020021220020687200_REF29","doi-asserted-by":"crossref","unstructured":"Liu K, Hodes RJ, Weng N. Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol. 2001;166: 4826-4830.","DOI":"10.4049\/jimmunol.166.8.4826"},{"key":"2020021220020687200_REF30","doi-asserted-by":"crossref","unstructured":"Rufer N, Brummendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood. 2001;98: 888-890.","DOI":"10.1182\/blood.V97.2.575"},{"key":"2020021220020687200_REF31","doi-asserted-by":"crossref","unstructured":"Zhu, J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci U S A. 1999;96: 3723-3728.","DOI":"10.1073\/pnas.96.7.3723"},{"key":"2020021220020687200_REF32","doi-asserted-by":"crossref","unstructured":"Cawthorn RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361: 393-395.","DOI":"10.1016\/S0140-6736(03)12384-7"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4440\/1698081\/zh801204004440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4440\/1698081\/zh801204004440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T01:28:28Z","timestamp":1581557308000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/12\/4440\/131380\/Elevated-telomerase-activity-and-minimal-telomere"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3079","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}